Hitto Kaufmann

Insider Reports History

Entity
Individual
Location
C/O Pieris Pharmaceuticals, Inc., 255 State Street, 9 Th Floor, Boston, MA
Signature
/s/ Ahmed Mousa, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Hitto Kaufmann:

Stock Role Class Num Shares Value Price $ Report Date Ownership
PIERIS PHARMACEUTICALS, INC. Chief Scientific Officer Stock Option (Right to buy) 249K Feb 24, 2023 Direct

Insider Reports Filed by Hitto Kaufmann

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PIRS PIERIS PHARMACEUTICALS, INC. Feb 24, 2023 1 $0 4 Feb 28, 2023 Chief Scientific Officer
PIRS PIERIS PHARMACEUTICALS, INC. Feb 22, 2022 1 $0 4 Feb 24, 2022 SVP, Chief Scientific Officer